Results 101 to 110 of about 14,528 (265)
Catheterization and Cardiovascular Interventions, Volume 106, Issue 3, Page 1873-1882, September 1, 2025.ABSTRACT Background Valve‐in‐valve (ViV) procedures are an established therapy. Self‐expanding (SE) supra‐annular transcatheter heart valves (THV) achieve superior hemodynamics compared to balloon‐expandable (BE) intra‐annular THV, but influence of stent design versus valve position remains unclear.
Antonia Katharina Stötzel +9 more
wiley +1 more source
Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States
Mycoses, Volume 68, Issue 9, September 2025.ABSTRACT Background Rezafungin, a novel echinocandin with once‐weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While clinical trial data support its efficacy and safety, real‐world experience remains limited.
Ilana Reinhold +24 more
wiley +1 more source
Chronic kidney disease and valvular heart disease: State of the art
Physiological Reports, Volume 13, Issue 18, September 2025.Abstract Chronic kidney disease (CKD) and valvular heart disease (VHD) frequently coexist and are associated with a significant increase in morbidity and mortality. Their interplay is complex and multifactorial, involving shared pathophysiological mechanisms such as chronic inflammation, mineral and bone disorder, vascular and valvular calcification ...
S. Saltarocchi +6 more
wiley +1 more source
Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement.
Annals of Thoracic and Cardiovascular Surgery, 2017 Trifecta is a stented bioprosthetic heart valve with a bovine pericardial sheet externally mounted on a titanium stent. This valve is applied only for aortic valve replacement (AVR), providing excellent hemodynamics and extremely low incidence of ...
M. Hamamoto +3 more
semanticscholar +1 more source
, 2007 Percutaneous valve replacement for severe aortic stenosis has shown to be an alternative treatment option for non-surgical candidates. We report on the first successful valve in valve procedure in an 80-year-old patient with a severe regurgitation of a ...
Buellesfeld, Lutz +3 more
core +1 more source
Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model
JACC: Basic to Translational Science, 2018 Visual ...
J. Navia +9 more
semanticscholar +1 more source
The mosaic bioprosthesis in the aortic position: 17 years' results.
, 2014 The Mosaic bioprosthesis (Medtronic Inc., Minneapolis, Minnesota, United States), a stented porcine aortic valve, combines glutaraldehyde fixation with zero-pressure, root-pressure techniques and antimineralization treatment with amino-oleic acid for ...
Gansera, Brigitte;Hapfelmeier, Alexander;Brandl, Kristina;Spiliopoulos, Kyriakos;Gundling, Felix;Eichinger, Walter
core +1 more source
Arquivos Brasileiros de Cardiologia, 2006 OBJETIVO: Apresentar os resultados imediatos e avaliar o desempenho clínico e hemodinâmico das biopróteses sem suporte de pericárdio bovino (stentless) em posição aórtica.
Wesley Ferreira de Araújo +6 more
doaj +1 more source
Late leaflet dehiscence in a bovine bioprosthesis-mimicked COVID-19 infection
, 2021 Symptoms mimicking COVID-19 infection, pulmonary emboli, or septicemia delayed diagnosis of aortic bioprosthesis failure. A 71-year-old man was admitted emergently with shortness of breath, fever, cough, and chest pain. Echocardiography performed after 2
Ivert, T, +3 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017 Background Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease.
Suengwon Lee +8 more
doaj +1 more source